Related Experiment Video
Updated: Aug 16, 2025

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Synthesis and Antiproliferative Effect of Halogenated Coumarin Derivatives
Tinuccia Dettori1, Giuseppina Sanna1, Andrea Cocco2
1Department of Biomedical Sciences, University of Cagliari, University Campus, 09042 Monserrato, CA, Italy.
Abstract:
A series of 6- and 6,8-halocoumarin derivatives have been investigated as potential antiproliferative compounds against a panel of tumor and normal cell lines. Cytotoxic effects were determined by the MTT method. To investigate the potential molecular mechanism involved in the cytotoxic effect, apoptosis assay, cell cycle analysis, reactive oxygen species (ROS), and reduced glutathione analysis were performed. Among the screened compounds, coumarins 6,8-dibromo-2-oxo-2H-chromene-3-carbonitrile 2h and 6,8-diiodo-2-oxo-2H-chromene-3-carbonitrile 2k exhibited the most antiproliferative effect in thyroid cancer-derived cells TPC-1. The apoptosis assay showed that both 2h and 2k induced apoptosis in TPC-1 thyroid cancer cells. According to these experiments, both coumarins induced a slight increase in TPC-1 cells in the G2/M phase and a decrease in the S phase. A significant increase in ROS levels was observed in TPC-1 treated with diiodocoumarin 2k, while the dibromocoumarin 2h induced a decrease in ROS in a dose and time-dependent manner.
Insights
New halogenated coumarin derivatives show antiproliferative effects against thyroid cancer cells. Compounds 2h and 2k induce apoptosis and alter cell cycle, with varying impacts on reactive oxygen species (ROS).
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Molecular Pharmacology
Background:
- Halogenated coumarin derivatives are explored for their potential anticancer properties.
- Thyroid cancer remains a significant health concern, necessitating novel therapeutic strategies.
- Understanding the molecular mechanisms of antiproliferative agents is crucial for drug development.
Purpose of the Study:
- To synthesize and evaluate 6- and 6,8-halocoumarin derivatives as potential antiproliferative agents.
- To investigate the molecular mechanisms underlying the cytotoxic effects of these compounds, including apoptosis, cell cycle, and oxidative stress.
- To identify specific halocoumarin derivatives with potent activity against thyroid cancer cells.
Main Methods:
- Synthesis of 6- and 6,8-halocoumarin derivatives.
- Cytotoxicity assessment using the MTT assay against various tumor and normal cell lines.
- Apoptosis assays, cell cycle analysis, reactive oxygen species (ROS) measurements, and reduced glutathione analysis to elucidate mechanisms of action.
Main Results:
- Compounds 6,8-dibromo-2-oxo-2H-chromene-3-carbonitrile (2h) and 6,8-diiodo-2-oxo-2H-chromene-3-carbonitrile (2k) demonstrated the most significant antiproliferative activity against TPC-1 thyroid cancer cells.
- Both 2h and 2k induced apoptosis in TPC-1 cells.
- Treatment with 2h and 2k led to a G2/M phase cell cycle arrest and a decrease in the S phase.
- Diiodocoumarin 2k significantly increased ROS levels, while dibromocoumarin 2h decreased ROS in a dose- and time-dependent manner.
Conclusions:
- Halogenated coumarin derivatives, particularly 2h and 2k, show promise as antiproliferative agents against thyroid cancer.
- The antiproliferative effects are mediated through the induction of apoptosis, cell cycle modulation, and alterations in oxidative stress.
- Further investigation into these compounds may lead to the development of novel thyroid cancer therapeutics.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
ortho–para-Directing Deactivators: Halogens
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Base-Promoted α-Halogenation of Aldehydes and Ketones

